Skip to main content
Log in

The effect of glycopyrrolate on the course of symptomatic duodenal ulcer

  • Published:
The American Journal of Digestive Diseases Aims and scope Submit manuscript

Summary

A double-blind controlled study of the effect of glycopyrrolate on 46 patients with duodenal ulcer is reported.

No beneficial effect of the drug over a period of 18–27 months could be demonstrated. Possible reasons for the difference between this study and that reported previously are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Sun, C. H. Long terra anticholinergic therapy for prevention of recurrences in duodenal ulcer.Amer J Dig Dis 9:706, 1964.

    Google Scholar 

  2. Jones, I. H. Riboflavine as an indicator of drug taking behavior.Med J Aust 1:5, 202, 1967.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Our thanks are due to the A. H. Robins Co., Richmond, Va. for the supply of tablets and for a grant in aid of this study. We also with to thank Dr. W. A. Sodeman for his cooperation, and Mrs. H. Waite for clerical assistance.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Trevino, H., Anderson, J., Davey, P.G. et al. The effect of glycopyrrolate on the course of symptomatic duodenal ulcer. Digest Dis Sci 12, 983–987 (1967). https://doi.org/10.1007/BF02233256

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02233256

Keywords

Navigation